# Does Switching to Nicotine-containing Electronic Cigarettes Reduce Health Risk Markers?

> **NIH NIH U01** · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2021 · $760,587

## Abstract

Project Summary/Abstract
Over the past ten years, a new inhaled nicotine device, popularly referred to as an electronic cigarette (e-cig),
has become increasingly popular around the world, particularly in the United States where more than 79% of
US adults are currently aware of the devices and 3.7% are using one on a regular basis. Current e-cig use is
most prevalent among current smokers (15.9%) and recent ex-smokers (22.0%) and is very uncommon among
adult never cigarette smokers (0.4%). As the popularity of these devices has increased, the types of devices
and the associated products available to users have diversified, making it difficult for users and non-users alike
to understand the devices and their potential harms or benefits. E-cigarettes deliver high doses of fine particles
and highly oxidizing free radicals in the human respiratory system. Fine particles are emitted when the solvents
propylene glycol and vegetable glycerin, along with flavors, additives and nicotine are aerosolized, and
respiratory and cardiovascular effects have been documented, but adequate assessments are lacking. The
recent development of a Standardized Research E-Cig (SREC) with both medium (15 mg/ml) and placebo
(zero mg/ml) nicotine concentration in the liquid now offers the possibility of testing the likely health effects of
attempting to switch from cigarette smoking to an SREC and to examine the effects of nicotine in the liquid on
that process. Our long term goal is to understand the likely health effects of cigarette smokers switching to a
Standardized Research E-Cig (SREC) and to assess the role of nicotine delivery on switching, acceptability
and markers of health outcomes. The specific objective of this proposal is to recruit a cohort of 240 current
exclusive daily smokers and to measure a comprehensive battery of health markers at baseline and at 3 and 6
weeks after attempting to switch completely to SRECs containing either zero or 15 mg/ml nicotine in a
randomized double-blind, placebo-controlled design. The NIH-funded Penn State Tobacco Center of
Regulatory Science has conducted a number of preliminary studies of electronic cigarette use. These studies
have provided us with the infrastructure and expertise to conduct a study of health risks associated with
switching to a Standardized Research E-Cig, with the following three specific aims: AIM 1. To characterize the
short-term effects of attempting to switch from traditional cigarette smoking to a Standardized Research E-Cig
using a comprehensive battery of measures (e.g. carcinogen biomarker, NNAL, pulmonary function testing,
lipid panel, glutathione, exhaled CO, blood nicotine and cotinine, BP etc.) over 6 weeks. AIM 2. To compare
the effects of nicotine containing versus zero nicotine liquid on reduction of smoking behavior and health
markers. AIM 3. At the end of each participant's 6 week participation they will be provided with information
about the health effects of tobacco product use, how to p...

## Key facts

- **NIH application ID:** 9752508
- **Project number:** 5U01DA045517-02
- **Recipient organization:** PENNSYLVANIA STATE UNIV HERSHEY MED CTR
- **Principal Investigator:** JONATHAN FOULDS
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $760,587
- **Award type:** 5
- **Project period:** 2018-08-15 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9752508

## Citation

> US National Institutes of Health, RePORTER application 9752508, Does Switching to Nicotine-containing Electronic Cigarettes Reduce Health Risk Markers? (5U01DA045517-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9752508. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*